Pham Dang Charles, Delécrin Joël, Péréon Yann, Falconi Isabelle, Passuti Norbert, Malinge Myriam, Pinaud Michel
Hôtel-Dieu, University Hospital of Nantes, 44093 France.
J Clin Anesth. 2008 Feb;20(1):17-24. doi: 10.1016/j.jclinane.2007.07.007.
To study the electrophysiologic and clinical effects of epidural morphine combined with either bupivacaine 0.125% or ropivacaine 0.2%.
Comparative, randomized, double-blind study.
Intensive care unit and hospital ward of a university hospital.
18 adult ASA physical status I and II patients with degenerative or idiopathic scoliosis, undergoing posterior spinal fusion with instrumentation.
Patients received epidural administration of 10-mL bolus of either bupivacaine or ropivacaine followed by a 6-mL/h infusion for 48 hours of unlabeled local anesthetic. In all patients, epidural morphine 5 mg was added daily.
Assessment was focused mainly on somatosensory cortical evoked potentials, soleus H-reflex, and F waves. These electrophysiologic data were recorded before and after epidural medications. Second, respiratory rate, Paco(2), visual analog score (VAS), and side effects such as postoperative nausea and vomiting (PONV), gastrointestinal (GI) transit delay, and urinary retention were noted.
Bupivacaine 0.125% + morphine was given to 9 patients, and ropivacaine 0.2% + morphine was given to 9 other patients. H-reflex, F waves, and somatosensory cortical evoked potential recording remained unchanged across the time of assessment. Respiratory rate and Paco(2) values were normal. VASs were indifferently low at rest, but they were lower with bupivacaine than with ropivacaine on mobilization. The frequency of PONV was indifferently high. No altered GI transit or urinary retention was noted.
After epidural administration during the study conditions, bupivacaine 0.125% and ropivacaine 0.2% combined with morphine allow for neurologic examination.
研究硬膜外吗啡联合0.125%布比卡因或0.2%罗哌卡因的电生理及临床效果。
比较、随机、双盲研究。
一所大学医院的重症监护病房和医院病房。
18例美国麻醉医师协会(ASA)身体状况为I级和II级的成年患者,患有退行性或特发性脊柱侧凸,正在接受后路脊柱融合内固定术。
患者接受硬膜外注射10毫升大剂量布比卡因或罗哌卡因,随后以6毫升/小时的速度输注48小时未标记的局部麻醉剂。所有患者每天加用5毫克硬膜外吗啡。
评估主要集中在体感皮层诱发电位、比目鱼肌H反射和F波。这些电生理数据在硬膜外用药前后记录。其次,记录呼吸频率、动脉血二氧化碳分压(Paco₂)、视觉模拟评分(VAS)以及术后恶心呕吐(PONV)、胃肠道(GI)转运延迟和尿潴留等副作用。
9例患者给予0.125%布比卡因+吗啡,另外9例患者给予0.2%罗哌卡因+吗啡。在评估期间,H反射、F波和体感皮层诱发电位记录保持不变。呼吸频率和Paco₂值正常。静息时VAS均较低,但活动时布比卡因组的VAS低于罗哌卡因组。PONV的发生率均较高。未发现胃肠道转运改变或尿潴留。
在研究条件下硬膜外给药后,0.125%布比卡因和0.2%罗哌卡因联合吗啡可进行神经学检查。